Feb 6 (Reuters) - Labcorp (LH.N), opens new tab forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on robust demand for its ...
Stocktwits on MSN2d
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment MixedA Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of Laboratory Corp. of America Holdings while downgrading Quest Diagnostics, ...
Labcorp (LH) announced the clinical availability of Labcorp Plasma Complete, a circulating tumor DNA-based comprehensive genomic profiling ...
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. "Labcorp Plasma Complete delivers ...
Labcorp Plasma Complete is a laboratory-developed test (LDT) and was validated in Labcorp's College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback